Evolutionary Genomics, Inc. (FNAM)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 2.35 Million USD | -19.73% |
| 2021 | 2.93 Million USD | -26.56% |
| 2020 | 3.99 Million USD | -5.89% |
| 2019 | 4.24 Million USD | -3.33% |
| 2018 | 4.38 Million USD | -18.72% |
| 2017 | 5.39 Million USD | -15.67% |
| 2016 | 6.4 Million USD | 101.92% |
| 2015 | 3.17 Million USD | 133.43% |
| 2014 | 1.35 Million USD | 136968.11% |
| 2013 | 991.00 USD | 52.23% |
| 2012 | 651.00 USD | 78.85% |
| 2011 | 364.00 USD | -0.27% |
| 2010 | 365.00 USD | -98.07% |
| 2009 | 18.95 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | 3.08 Million USD | -11.85% |
| 2022 Q1 | 3.5 Million USD | 19.54% |
| 2022 FY | 2.35 Million USD | -19.73% |
| 2022 Q4 | 2.35 Million USD | -12.42% |
| 2022 Q3 | 2.68 Million USD | -13.02% |
| 2021 Q3 | 3.56 Million USD | 10.14% |
| 2021 Q2 | 3.23 Million USD | -10.35% |
| 2021 Q1 | 3.61 Million USD | -9.55% |
| 2021 FY | 2.93 Million USD | -26.56% |
| 2021 Q4 | 2.93 Million USD | -17.77% |
| 2020 Q3 | 4.45 Million USD | 6.86% |
| 2020 Q2 | 4.17 Million USD | 0.01% |
| 2020 Q1 | 4.16 Million USD | -1.71% |
| 2020 FY | 3.99 Million USD | -5.89% |
| 2020 Q4 | 3.99 Million USD | -10.4% |
| 2019 Q1 | 4.26 Million USD | -2.89% |
| 2019 Q2 | 4.58 Million USD | 7.68% |
| 2019 FY | 4.24 Million USD | -3.33% |
| 2019 Q3 | 4.43 Million USD | -3.44% |
| 2019 Q4 | 4.24 Million USD | -4.26% |
| 2018 Q1 | 5.13 Million USD | -4.92% |
| 2018 Q2 | 4.79 Million USD | -6.64% |
| 2018 FY | 4.38 Million USD | -18.72% |
| 2018 Q4 | 4.38 Million USD | -3.56% |
| 2018 Q3 | 4.55 Million USD | -5.05% |
| 2017 Q4 | 5.39 Million USD | -0.05% |
| 2017 Q2 | 5.62 Million USD | -7.65% |
| 2017 Q3 | 5.4 Million USD | -3.96% |
| 2017 Q1 | 6.09 Million USD | -4.87% |
| 2017 FY | 5.39 Million USD | -15.67% |
| 2016 Q4 | 6.4 Million USD | 23.51% |
| 2016 FY | 6.4 Million USD | 101.92% |
| 2016 Q3 | 5.18 Million USD | -2.7% |
| 2016 Q2 | 5.32 Million USD | -5.4% |
| 2016 Q1 | 5.63 Million USD | 77.61% |
| 2015 Q3 | 5000.00 USD | -33.33% |
| 2015 FY | 3.17 Million USD | 133.43% |
| 2015 Q4 | 3.17 Million USD | 63316.6% |
| 2015 Q1 | 10 Thousand USD | -99.26% |
| 2015 Q2 | 7500.00 USD | -25.0% |
| 2014 Q2 | 831.00 USD | 7.78% |
| 2014 FY | 1.35 Million USD | 136968.11% |
| 2014 Q4 | 1.35 Million USD | 1131854.17% |
| 2014 Q1 | 771.00 USD | -22.2% |
| 2014 Q3 | 120.00 USD | -85.56% |
| 2013 Q2 | 948.00 USD | 143.7% |
| 2013 FY | 991.00 USD | 52.23% |
| 2013 Q4 | 991.00 USD | 60.88% |
| 2013 Q3 | 616.00 USD | -35.02% |
| 2013 Q1 | 389.00 USD | -40.25% |
| 2012 FY | 651.00 USD | 78.85% |
| 2012 Q2 | 189.00 USD | -35.49% |
| 2012 Q1 | 293.00 USD | -19.51% |
| 2012 Q3 | 159.00 USD | -15.87% |
| 2012 Q4 | 651.00 USD | 309.43% |
| 2011 Q1 | 319.00 USD | -12.6% |
| 2011 FY | 364.00 USD | -0.27% |
| 2011 Q4 | 364.00 USD | 304.44% |
| 2011 Q3 | 90.00 USD | -55.22% |
| 2011 Q2 | 201.00 USD | -36.99% |
| 2010 Q4 | 365.00 USD | -93.64% |
| 2010 FY | 365.00 USD | -98.07% |
| 2010 Q3 | 5736.00 USD | 0.0% |
| 2009 Q4 | 18.95 Thousand USD | 0.0% |
| 2009 FY | 18.95 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| America Great Health | 299.12 Thousand USD | -686.855% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| Innovation1 Biotech Inc. | 75.99 Thousand USD | -2997.272% |
| Point of Care Nano-Technology, Inc. | 124.64 Thousand USD | -1788.361% |
| Vicapsys Life Sciences, Inc. | 39.65 Thousand USD | -5835.319% |